Open AccessSacituzumab govitecan in metastatic triple-negative breast cancer
Author(s) -
A. Bardia,
S.A. Hurvitz,
S.M. Tolaney,
D. Loirat,
K. Punie,
M. Oliveira,
A. Brufsky,
S.D. Sardesai,
K. Kalinsky,
A.B. Zelnak,
R. Weaver,
T. Traina,
F. Dalenc,
P. Aftimos,
F. Lynce,
S. Diab,
J. Cortés,
J. O apos Shaughnessy,
V. Diéras,
C. Ferrario,
P. Schmid,
L.A. Carey,
L. Gianni,
M.J. Piccart,
S. Loibl,
D.M. Goldenberg,
Q. Hong,
M.S. Olivo,
L.M. Itri,
H.S. Rugo,
ASCENT Clinical Trial Investigators
Publication year - 2021
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - Uncategorized
DOI - 10.17615/2tmz-ff35
Subject(s) - triple negative breast cancer , metastatic breast cancer , breast cancer , triple negative , medicine , oncology , cancer
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom